Aromatase in endometriosis and uterine leiomyomata

Journal of Steroid Biochemistry and Molecular Biology

Volumn 95, Issue 1-5, 2005, Pages 57-62

  Bulun, Serdar E ^a   Imir, Gonca ^a   Utsunomiya, Hiroki ^a   Thung, Steven ^a   Gurates, Bilgin ^a   Tamura, Mitsutoshi ^a   Lin, Zhihong ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Anastrozole; Aromatase; Aromatase inhibitor; Endometriosis; Endometrium; Estrogen; Estrogen biosynthesis; Letrozole; Uterine leiomyomata; Uterus

Indexed keywords

ANASTROZOLE; ANDROSTENEDIONE; AROMATASE; AROMATASE INHIBITOR; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; GONADORELIN DERIVATIVE; LETROZOLE; MEGESTROL ACETATE; MESSENGER RNA; NORETHISTERONE ACETATE; PROSTAGLANDIN E2; STEROIDOGENIC FACTOR 1;

CLINICAL TRIAL; CONFERENCE PAPER; ENDOMETRIOSIS; ENZYME ACTIVITY; ENZYME REGULATION; ESTROGEN METABOLISM; ESTROGEN RELEASE; ESTROGEN SYNTHESIS; FEEDBACK SYSTEM; HOT FLUSH; HUMAN; MOLECULAR MECHANICS; MUELLERIAN DUCT; OSTEOLYSIS; PARACRINE SIGNALING; PELVIS PAIN SYNDROME; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SALPINGOOOPHORECTOMY; SIDE EFFECT; UTERINE LEIOMYOMATA; UTERUS BLEEDING; UTERUS DISEASE;

AROMATASE; AROMATASE INHIBITORS; ENDOMETRIOSIS; ESTROGENS; FEMALE; HUMANS; LEIOMYOMA; UTERINE NEOPLASMS; UTERUS;

EID: 23744448867     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.04.012     Document Type: Conference Paper

References (32)

1. M.P. Vessey, L. Villard-Mackintosh, and R. Painter Epidemiology of endometriosis in women attending family planning clinics Br. Med. J. 306 1993 182 184
2. K.H. Kjerulff, B.A. Erickson, and P.W. Langenberg Chronic gynecological conditions reported by US women: findings from the National Health Information Survey, 1984 to 1992 Am. J. Public Health 86 1996 195 199
3. D.L. Olive, and L.B. Schwartz Endometriosis N. Engl. J. Med. 328 1993 1759 1769
4. J.A. Sampson Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity Am. J. Obstet. Gynecol. 14 1927 422 425
5. J. Halme, C. White, S. Kauma, J. Estes, and S. Haskill Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro J. Clin. Endocrinol. Metab. 66 1988 1044 1049
6. L.S. Noble, E.R. Simpson, A. Johns, and S.E. Bulun Aromatase expression in endometriosis J. Clin. Endocrinol. Metab. 81 1996 174 179
7. K. Zeitoun, K. Takayama, M.D. Michael, and S.E. Bulun Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of SF-1 and COUP-TF to the same cis-acting element Mol. Endocrinol. 13 1999 239 253
8. O. Khorram, R.N. Taylor, I.P. Taylor, T.J. Schall, and D.V. Landers Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis Am. J. Obstet. Gynecol. 169 1993 1545 1549
9. K.L. Sharpe-Timms, L.L. Penny, R.L. Zimmer, J.A. Wright, Y. Zhang, and K. Surewicz Partial purification and amino acid sequence analysis of endometriosis protein-II (ENDO-II) reveals homology with tissue inhibitor of metalloproteinases-1 (TIMP-1) J. Clin. Endocrinol. Metab. 80 1995 3784 3787
10. K.L. Bruner, L.M. Matrisian, W.H. Rogers, F. Gorstein, and K.G. Osteen Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice J. Clin. Invest. 99 1997 2851 2857
11. K.G. Osteen, K.L. Bruner, and K.L. Sharpe-Timms Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis Semin. Reprod. Endocrinol. 15 1996 301 308
12. K. Zeitoun, K. Takayama, H. Sasano, T. Suzuki, N. Moghrabi, S. Andersson, A. Johns, L. Meng, M. Putman, B. Carr, and S.E. Bulun Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize estradiol-17β J. Clin. Endocrinol. Metab. 83 1998 4474 4480
13. M.D. Michael, L.F. Michael, and E.R. Simpson A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene Mol. Cell. Endocrinol. 134 1997 147 156
14. M.D. Michael, M.W. Kilgore, K.I. Morohashi, and E.R. Simpson Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary J. Biol. Chem. 270 1995 13561 13566
15. E.R. Simpson, M.S. Mahendroo, G.D. Means, M.W. Kilgore, M.M. Hinshelwood, S. Grahm-Lorence, B. Amameh, Y. Ito, C.R. Fisher, M.D. Michael, C.R. Mendelson, and S.E. Bulun Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis Endocr. Rev. 15 1994 342 355
16. G.E. Ackerman, M.E. Smith, C.R. Mendelson, P.C. MacDonald, and E.R. Simpson Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture J. Clin. Endocrinol. Metab. 53 1981 412 417
17. 4-androstenedione to estrone in normal males and non-pregnant normal, castrate and adrenalectomized females J. Clin. Endocrinol. Metab. 27 1967 1103 1111
18. P.C. MacDonald, C.D. Edman, D.L. Hemsdell, J.C. Porter, and P.K. Siiter Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer Am. J. Obstet. Gynecol. 130 1978 448 455
19. S.E. Bulun, T.M. Price, M.S. Mahendroo, J. Aitken, and E.R. Simpson A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription J. Clin. Endocrinol. Metab. 77 1993 1622 1628
20. W. Yue, J.P. Wang, C.J. Hamilton, L.M. Demers, and R.J. Santen In situ aromatization enhances breast tumor estradiol levels and cellular proliferation Cancer Res. 58 1998 927 932
21. S.E. Bulun, E.R. Simpson, and R.A. Word Expression of the CYP19 gene and its product aromatase cytochrome P450 in human leiomyoma tissues and cells in culture J. Clin. Endocrinol. Metab. 78 1994 736 743
22. 2 stimulates aromatase expression in endometriosis-derived stromal cells J. Clin. Endocrinol. Metab. 82 1997 600 606
23. S.E. Bulun, M.S. Mahendroo, and E.R. Simpson Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or decidua J. Clin. Endocrinol. Metab. 76 1993 1458 1463
24. M. Tamura, S. Deb, S. Sebastian, O. Kunihiro, and S.E. Bulun Estrogen up-regulates cyclooxygenase-2 via estrogen receptor in human uterine microvascular endothelial cells Fertil. Steril. 81 2004 1351 1356
25. J.A. Hill Immunology and endometriosis Fertil. Steril. 58 1992 262 264
26. K. Takayama, K. Zeitoun, R.T. Gunby, H. Sasano, B.R. Carr, and S.E. Bulun Treatment of severe postmenopausal endometriosis with an aromatase inhibitor Fertil. Steril. 69 1998 709 713
27. R.K. Ailawadi, S. Jobanputras, Meera, B. Gurates, and S.E. Bulun Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study Fertil. Steril. 81 2004 290 296
28. S.E. Bulun, E.R. Simpson, and R.A. Word Expression of the CYP19 gene and its product aromatase cytochrome P450 in human leiomyoma tissues and cells in culture J. Clin. Endocrinol. Metab. 78 1994 736 743
29. H. Sumitani, M. Shozu, T. Segawa, H.J. Yang, K. Murakami, and M. Inove In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism Endocrinology 141 2000 3852 3861
30. M. Shozu, H. Sumitani, T. Segawa, K. Murakami, H.J. Yang, and M. Inove Inhibition of in situ expression of aromatase P450 in leiomyoma of the uterus by leuprorelin acetate J. Clin. Endocrinol. Metab. 86 2001 5405 5411
31. M. Shozu, H. Sumitani, T. Segawa, H.J. Yang, K. Murakami, T. Kasai, and M. Inove Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19) J. Clin. Endocrinol. Metab. 87 2002 2540 2548
32. M. Shozu, K. Murakami, T. Segawa, T. Kasai, and M. Inove Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor Fertil. Steril. 79 2003 628 631